• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by Ecovyst Inc.

    5/4/26 7:44:46 AM ET
    $ECVT
    Major Chemicals
    Industrials
    Get the next $ECVT alert in real time by email
    8-K
    false 0001708035 0001708035 2026-05-01 2026-05-01
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): May 1, 2026

     

     

    Ecovyst Inc.

    (Exact Name of Registrant as Specified in its Charter)

     

     

    Commission File Number: 001-38221

     

    Delaware   81-3406833
    (State or other jurisdiction of
    incorporation or organization)
      (I.R.S. Employer
    Identification No.)

     

    600 Lee Road, Suite 200  
    Wayne, Pennsylvania   19087
    (Address of principal executive offices)   (Zip Code)

    (484) 617-1200

    (Registrant’s telephone number, including area code)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    symbol

     

    Name of each exchange
    on which registered

    Common stock, par value $0.01 per share   ECVT   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 1.01

    Entry into a Material Definitive Agreement.

    On May 1, 2026, Ecovyst Inc. (the “Company”), through its wholly owned subsidiaries New Structure Subco Inc. (the “US Purchaser”) and EV Industrial Chemical Subsidiary Holdings Inc. (the “Canadian Purchaser” and, together with the US Purchaser, the “Purchasers”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with INEOS Calabrian Holdings Limited (the “US Seller”) and INEOS Calabrian Canada Holdings Limited (the “Canadian Seller” and, together with the US Seller, the “Sellers”), pursuant to which the Purchasers will acquire the entire issued share capital of INEOS Calabrian Holdings Corp. (the “US Target”) and INEOS Calabrian Corporation Canada, Inc. (the “Canadian Target”) (the “Transaction”). The Transaction is expected to be completed in the second quarter of 2026.

    Pursuant to the Purchase Agreement, the Purchasers will pay a purchase price of $190 million (the “Purchase Price”), subject to certain customary adjustments specified therein, including for cash and working capital.

    The Purchase Agreement contains customary warranties and covenants by each party that are subject, in some cases, to specified exceptions and qualifications as set out in the Purchase Agreement. The Sellers have provided customary fundamental, business and tax warranties, with the fundamental, business and tax warranties to be repeated at closing. The Purchasers are procuring a warranty and indemnity insurance policy at their own cost, which will provide recourse for any fundamental, business warranty claims and tax covenant claims (other than claims based on fraud). The Purchase Agreement contains limited indemnities.

    Each party’s obligation to consummate the Transaction pursuant to the Purchase Agreement is subject to the satisfaction or waiver of customary closing conditions as set out therein.

    The Purchase Agreement includes customary termination rights and is governed by English law, with disputes to be resolved by ICC arbitration.

    The foregoing description of the Purchase Agreement does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the full text of the Purchase Agreement, which is attached hereto as Exhibit 2.1 to this Current Report on Form 8-K, and is incorporated herein by reference.

    Note on Forward-Looking Statements

    Some of the information contained in this Form 8-K constitutes “forward-looking statements.” Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects,” “projects,” “aims” and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Examples of forward-looking statements include, but are not limited to, the timing of the closing of the Transaction, the ability to satisfy or waive the conditions to completion, and the ability to complete the Transaction considering the various closing conditions. Actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: the possibility that the conditions to the closing of the Transaction are not satisfied, including the risk that a Material Adverse Change occurs; the occurrence of any event, change or other circumstance that could give rise to a right to terminate the Transaction; unexpected costs, liabilities or delays in connection with the Transaction; legal proceedings initiated in connection with the Transaction; risks related to the integration of the acquired business; regional, national or global political, economic, business, competitive, market and regulatory conditions, including the enactment, schedule and impact of tariffs and trade disputes; currency exchange rates; the effects of inflation; and other factors, including those described in the sections titled “Risk Factors” and “Management’s Discussion & Analysis of Financial Condition and Results of Operations” in our filings with the SEC, which are available on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date of this Form 8-K. Factors or events that could cause our actual results to differ may emerge


    from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit
    No.

      

    Description

     2.1    Share Purchase Agreement, dated as of May 1, 2026, by and among INEOS Calabrian Holdings Limited, INEOS Calabrian Canada Holdings Limited, INEOS Enterprises Holdings Limited, Ecovyst Inc., New Structure Subco Inc. and EV Industrial Chemical Subsidiary Holdings Inc.*
    104    The cover page from this Current Report on Form 8-K of Ecovyst Inc., formatted in Inline XBRL and included as Exhibit 104

     

    *

    Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the U.S. Securities and Exchange Commission upon request.

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: May 4, 2026   Ecovyst Inc.
        By:  

    /s/ Michael Feehan

        Name:   Michael Feehan
        Title:   Vice President and Chief Financial Officer
    Get the next $ECVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ECVT

    DatePrice TargetRatingAnalyst
    9/16/2025$10.50Buy → Neutral
    Citigroup
    9/11/2023$12.00Buy
    Citigroup
    3/23/2022$18.00Buy
    BWS Financial
    3/2/2022$16.00 → $13.00Buy
    Deutsche Bank
    2/28/2022$18.00 → $16.00Overweight
    Keybanc
    11/29/2021$10.80Neutral
    Citigroup
    8/17/2021$21.00 → $18.00Overweight
    Keybanc
    8/16/2021$15.00 → $12.50Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ECVT
    SEC Filings

    View All

    Ecovyst Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Ecovyst Inc. (0001708035) (Filer)

    5/21/26 4:02:36 PM ET
    $ECVT
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Ecovyst Inc.

    SCHEDULE 13G/A - Ecovyst Inc. (0001708035) (Subject)

    5/8/26 3:47:20 PM ET
    $ECVT
    Major Chemicals
    Industrials

    SEC Form 10-Q filed by Ecovyst Inc.

    10-Q - Ecovyst Inc. (0001708035) (Filer)

    5/5/26 4:00:47 PM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Whittleston Paul bought $50,739 worth of shares (7,800 units at $6.50), increasing direct ownership by 16% to 57,542 units (SEC Form 4)

    4 - Ecovyst Inc. (0001708035) (Issuer)

    8/8/24 4:01:00 PM ET
    $ECVT
    Major Chemicals
    Industrials

    Officer Koscinski Joseph S. bought $30,090 worth of shares (4,807 units at $6.26), increasing direct ownership by 0.89% to 544,609 units (SEC Form 4)

    4 - Ecovyst Inc. (0001708035) (Issuer)

    8/6/24 4:01:29 PM ET
    $ECVT
    Major Chemicals
    Industrials

    Officer Feehan Michael bought $100,542 worth of shares (16,000 units at $6.28), increasing direct ownership by 5% to 364,799 units (SEC Form 4)

    4 - Ecovyst Inc. (0001708035) (Issuer)

    8/6/24 4:01:10 PM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lorance Sarah sold $112,638 worth of shares (8,450 units at $13.33), decreasing direct ownership by 13% to 54,700 units (SEC Form 4)

    4 - Ecovyst Inc. (0001708035) (Issuer)

    6/3/26 4:01:47 PM ET
    $ECVT
    Major Chemicals
    Industrials

    Director Humble Patti A. was granted 9,099 shares (SEC Form 4)

    4 - Ecovyst Inc. (0001708035) (Issuer)

    5/27/26 4:02:18 PM ET
    $ECVT
    Major Chemicals
    Industrials

    SEC Form 3 filed by new insider Humble Patti A.

    3 - Ecovyst Inc. (0001708035) (Issuer)

    5/26/26 4:04:12 PM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ecovyst Completes Term Loan Amendment and Increase

    WAYNE, Pa., May 14, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE:ECVT) ("Ecovyst" or the "Company"), a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services, today announced that it has completed the syndication of a $100 million fungible Term Loan B add-on, which it intends to use to finance a portion of its pending acquisition of the Calabrian sulfur dioxide and sulfur derivatives business from INEOS Enterprises.  The acquisition and the add-on are anticipated to close by the end of the second quarter of 2026.  The add-on was issued at par and is co-terminus with the Company's existing $397 million Term Loan B, due June 2031, at a floating rate of SOFR plu

    5/14/26 7:10:00 PM ET
    $ECVT
    Major Chemicals
    Industrials

    Ecovyst Announces Term Loan Amendment and Increase

    WAYNE, Pa., May 11, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE:ECVT) ("Ecovyst" or the "Company"), a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services, today announced that it intends to issue a $100 million fungible Term Loan B add-on to finance its pending acquisition of the Calabrian sulfur dioxide and related sulfur derivatives business from INEOS Enterprises, which is targeted to close by the end of the second quarter 2026, along with cash on the balance sheet. The add-on is expected to be co-terminus with the Company's existing $397 million Term Loan B due June 2031.

    5/11/26 8:05:00 AM ET
    $ECVT
    Major Chemicals
    Industrials

    Ecovyst Reports First Quarter 2026 Results and Revises 2026 Outlook

    WAYNE, Pa., May 5, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE:ECVT) ("Ecovyst" or the "Company"), a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services, today reported results for the first quarter ended March 31, 2026. On December 31, 2025, the Company completed the sale of its Advanced Materials & Catalysts business, which includes the Company's investment in affiliated companies, Zeolyst International and Zeolyst C.V. Financial results of the divested Advanced Materials & Catalysts business are reported in discontinued operations in the f

    5/5/26 6:00:00 AM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ecovyst downgraded by Citigroup with a new price target

    Citigroup downgraded Ecovyst from Buy to Neutral and set a new price target of $10.50

    9/16/25 8:02:50 AM ET
    $ECVT
    Major Chemicals
    Industrials

    Citigroup initiated coverage on Ecovyst with a new price target

    Citigroup initiated coverage of Ecovyst with a rating of Buy and set a new price target of $12.00

    9/11/23 7:19:57 AM ET
    $ECVT
    Major Chemicals
    Industrials

    BWS Financial initiated coverage on Ecovyst with a new price target

    BWS Financial initiated coverage of Ecovyst with a rating of Buy and set a new price target of $18.00

    3/23/22 9:07:43 AM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Financials

    Live finance-specific insights

    View All

    Ecovyst Reports First Quarter 2026 Results and Revises 2026 Outlook

    WAYNE, Pa., May 5, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE:ECVT) ("Ecovyst" or the "Company"), a leading provider of virgin sulfuric acid and regenerated sulfuric acid products and services, today reported results for the first quarter ended March 31, 2026. On December 31, 2025, the Company completed the sale of its Advanced Materials & Catalysts business, which includes the Company's investment in affiliated companies, Zeolyst International and Zeolyst C.V. Financial results of the divested Advanced Materials & Catalysts business are reported in discontinued operations in the f

    5/5/26 6:00:00 AM ET
    $ECVT
    Major Chemicals
    Industrials

    Ecovyst to Host First Quarter 2026 Earnings Conference Call and Webcast on Tuesday, May 5, 2026 at 11:00 a.m. ET

    WAYNE, Pa., April 20, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE:ECVT), a leading provider of virgin sulfuric acid, sulfuric acid regeneration services and ex-situ catalyst activation services announced today that it will conduct a conference call and audio-only webcast on Tuesday, May 5, 2026 at 11:00 a.m. Eastern Time to review its first quarter 2026 financial results. Investors may listen to the conference call live via telephone by dialing 1 (800) 245-3047 (domestic) or 1 (203) 518-9765 (international) and use the participant code ECVTQ126.An audio-only live webcast of the conf

    4/20/26 12:07:00 PM ET
    $ECVT
    Major Chemicals
    Industrials

    Ecovyst Reports Fourth Quarter and Full Year 2025 Results

    WAYNE, Pa., Feb. 26, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE:ECVT) ("Ecovyst" or the "Company"), a leading integrated provider of virgin and regenerated sulfuric acid products and services, today reported results for the fourth quarter and full year ended December 31, 2025. The financial results of the divested Advanced Materials & Catalysts business are reported in discontinued operations in the financial statements for all periods presented.Fourth Quarter 2025 Results & Highlights from Continuing OperationsCompleted sale of Advanced Materials & Catalysts segment to Technip Ene

    2/26/26 6:00:00 AM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Leadership Updates

    Live Leadership Updates

    View All

    Glatfelter Announces Key Leadership Appointments in Connection With Proposed Merger With Berry's Health, Hygiene, and Specialties Global Nonwovens and Films Business

    ~ Kevin M. Fogarty to serve as Non-Executive Chair of the Board of Directors for the proposed newly combined company ~ James M. Till to serve as Executive Vice President, Chief Financial Officer & Treasurer ~ Tarun Manroa to serve as Executive Vice President, Chief Operating Officer CHARLOTTE, N.C., April 11, 2024 (GLOBE NEWSWIRE) -- Glatfelter Corporation (NYSE:GLT), a leading global supplier of engineered materials, in anticipation of the previously announced proposed merger of the majority of Berry Global's Health, Hygiene, and Specialties segment to include its Global Nonwovens and Films ("HHNF") business with Glatfelter, is pleased to announce today key leadership appointments, in

    4/11/24 6:50:00 AM ET
    $BERY
    $ECVT
    $GLT
    Plastic Products
    Industrials
    Major Chemicals
    Paper

    Ecovyst Appoints Colleen Grace Donofrio as Vice President – Environment and Sustainability

    Ecovyst Inc. (NYSE:ECVT) ("Ecovyst" or the "Company"), a leading integrated and innovative global provider of specialty catalysts and services, today announced that Colleen Grace Donofrio has been appointed as its Vice President – Environment and Sustainability. "I am excited to have Colleen join the team to lead our environmental and sustainability programs," said Kurt Bitting, Chief Executive Officer of Ecovyst. "Colleen's experience and enthusiasm will help further enhance Ecovyst's award winning sustainability programs and bolster our efforts to develop service offerings that enable our customers to meet their sustainability goals. Mrs. Donofrio most recently served as a shareholder

    8/21/23 6:30:00 AM ET
    $ECVT
    Major Chemicals
    Industrials

    Ecovyst Inc. Appoints Gene Shiels to Lead Investor Relations

    Ecovyst Inc. (NYSE:ECVT) ("Ecovyst"), a leading integrated and innovative global provider of specialty catalysts and services, today announced that it has appointed Gene Shiels as Director of Investor Relations. Mr. Shiels will report to Mike Feehan, Chief Financial Officer of Ecovyst. Mr. Shiels has more than 18 years of experience in Investor Relations. Most recently, he served as Director of Investor Relations at Kraton Corporation, a position he held from 2010 until the company's sale in March of 2022. Prior to that role, he held positions of increasing responsibility at Baker Hughes Incorporated, including Assistant Director of Investor Relations and Assistant Treasurer. Mr. Shiels ho

    5/2/22 6:59:00 AM ET
    $ECVT
    Major Chemicals
    Industrials

    $ECVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ecovyst Inc.

    SC 13G/A - Ecovyst Inc. (0001708035) (Subject)

    9/10/24 3:20:20 PM ET
    $ECVT
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Ecovyst Inc. (Amendment)

    SC 13G/A - Ecovyst Inc. (0001708035) (Subject)

    2/13/24 5:04:42 PM ET
    $ECVT
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by Ecovyst Inc.

    SC 13G - Ecovyst Inc. (0001708035) (Subject)

    2/13/24 4:04:48 PM ET
    $ECVT
    Major Chemicals
    Industrials